Neuronal Loss in Alzheimer's Disease Only Moderate
Frequently encountered in the elderly, Alzheimer’s is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint French and Canadian study published in Scientific Reports now challenges this view.
Conducted among more than 170 subjects at various stages of Alzheimer’s disease, the study by the team led by Salah El Mestikawy (Douglas Mental Health University Institute, Canada) and Stéphanie Daumas (Université Pierre et Marie Curie, France) has shown instead that the disease is accompanied by a minor decline in neuronal and synaptic markers.
“Much to our surprise, in studying the fate of eight neuronal and synaptic markers in our subjects’ prefrontal cortices, we only observed very minor neuronal and synaptic losses. Our study therefore suggests that, contrary to what was believed, neuronal and synaptic loss is relatively limited in Alzheimer’s disease. This is a radical change in thinking,” explains El Mestikawy, an associate professor at McGill University.
The scientists also attempted to correlate all these minor synaptic losses with the subjects’ level of dementia. Their results show that the declines in synaptic biomarkers had little impact on the participants’ cognitive skills.
Towards other therapies
The study implicitly suggests that dementia is associated with a synaptic dysfunction rather than the disappearance of synapses from the patient’s cortex. Identifying this dysfunction could lead to the development of effective treatments for this disease.
“Until now, therapeutic interventions have been aimed at slowing synaptic destruction. Based on our study, we are going to have to change our therapeutic approach,” says El Mestikawy.
According to the Alzheimer Society of Canada, 564,000 Canadians currently have Alzheimer’s disease or another form of dementia. The figure will be 937,000 within 15 years. Presently, there is no truly effective treatment for this disease.
This article has been republished from materials provided by McGill University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Poirel, O., Mella, S., Videau, C., Ramet, L., Davoli, M. A., Herzog, E., . . . Mestikawy, S. E. (2018). Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages. Scientific Reports, 8(1). doi:10.1038/s41598-018-19154-y
Researchers Democratize Neuroscience by Making it Easier to Share Brain Imaging DataNews
Researchers have developed a set of tools to make one critical area of big data research — that of our central nervous system — easier to share.READ MORE
Neuroscientists Identify The Retrosplenial Cortex as an Integrator of Vision and Head MovementNews
Study highlights role of primary visual cortex in integrating head and visual movement signalsREAD MORE
So Hot it Hurts: Ion channel trio underlying painful heat sensation foundNews
Researchers show that acute noxious heat sensing in mice depends on a triad of transient receptor potential (TRP) ion channels: TRPM3, TRPV1, and TRPA1.READ MORE